GlobeNewswire Inc | Feb 19, 2021 08:00AM EST

February 19, 2021

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc.(Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced thatSharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the SVB Leerink 10th Annual Global Healthcare Conference on Friday, February 26, 2021at10:00 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website atwww.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

AboutIntra-Cellular TherapiesIntra-Cellular Therapiesis a biopharmaceutical company founded onNobelprize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

CONTACT:Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Lisa BurnsJohn Grimaldijgrimaldi@burnsmc.com212-213-0006